A phase I, first in human, open-label, dose finding study evaluating the safety and pharmacokinetics of AMG 706 [motesanib] in subjects with advanced solid tumors
Phase of Trial: Phase I
Latest Information Update: 14 May 2013
At a glance
- Drugs Motesanib (Primary)
- Indications Breast cancer; Carcinoid tumour; Colorectal cancer; Gastrointestinal stromal tumours; Sarcoma; Solid tumours; Thyroid cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 10 Jun 2007 Results have been published.
- 27 Sep 2005 New trial record.